KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Operating Margin (2016 - 2025)

Historic Operating Margin for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to 18.09%.

  • Abbott Laboratories' Operating Margin rose 6100.0% to 18.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.59%, marking a year-over-year increase of 13500.0%. This contributed to the annual value of 16.27% for FY2024, which is 1200.0% up from last year.
  • Per Abbott Laboratories' latest filing, its Operating Margin stood at 18.09% for Q3 2025, which was up 6100.0% from 18.42% recorded in Q2 2025.
  • Abbott Laboratories' Operating Margin's 5-year high stood at 24.48% during Q1 2022, with a 5-year trough of 12.92% in Q4 2022.
  • In the last 5 years, Abbott Laboratories' Operating Margin had a median value of 17.38% in 2023 and averaged 17.66%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 103600bps in 2021, then crashed by -90000bps in 2023.
  • Abbott Laboratories' Operating Margin (Quarter) stood at 20.74% in 2021, then crashed by -38bps to 12.92% in 2022, then soared by 35bps to 17.38% in 2023, then increased by 0bps to 17.41% in 2024, then increased by 4bps to 18.09% in 2025.
  • Its Operating Margin stands at 18.09% for Q3 2025, versus 18.42% for Q2 2025 and 16.34% for Q1 2025.